Ritu Salani, MD, MBA, discusses the current state of biomarker testing in cervical cancer.
Ritu Salani, MD
Advertisement
Ritu Salani, MD, MBA, is a board-certified gynecologic oncologist who is a nationally renowned expert in the treatment of gynecologic malignancies with over 15 years of experience. She serves as the Director of Gynecologic Oncology at UCLA.
Articles by Ritu Salani, MD
Ritu Salani, MD, discusses opportunities for precision medicine in cervical cancer.
Ritu Salani, MD, discusses opportunities for precision medicine in cervical cancer.
Ritu Salani, MD, provides insight into how to approach selection of chemotherapy in ovarian cancer.
Ritu Salani, MD, discusses the progression of upfront ovarian cancer treatment.
Ritu Salani, MD, discusses selecting patients with ovarian cancer for primary debulking surgery versus neoadjuvant chemotherapy.
Ritu Salani, MD, discusses considerations for neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Ritu Salani, MD, discusses the potential of targeted therapy and immunotherapy in cervical cancer.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Dr Johnson on Immune Activation With Indoximod-Based Chemo-Immunotherapy in Recurrent Ependymoma
2
Tovorafenib Sustains Treatment-Free Intervals in R/R BRAF-Altered Pediatric Low-Grade Glioma
3
Dr Miller on Whole Genome Sequencing of CSF ctDNA in High-Grade Glioma
4
Patient Preferences Steer Decisions as Options Multiply Across EGFR-Mutated NSCLC
5